dual solutions
Dual solutions in MHD flow on a nonlinear porous shrinking sheet in a viscous fluid
7
Unsteady Heat and Mass Transfer Near the Stagnation-point on a Vertical Permeable Surface: a Comprehensive Report of Dual Solutions
10
Dual solutions of stagnation-point flow of a nanofluid over a stretching surface
12
Dual solutions in MHD Boundary Layer Flow of Carreau Fluidover a Shrinking Sheet with Convective Boundary Condition
9
Dual solutions of a boundary layer problem for MHD nanofluids through a permeable wedge with variable viscosity
13
DUAL SOLUTIONS FOR HEAT AND MASS TRANSFER IN MHD JEFFREY FLUID IN THE PRESENCE OF HOMOGENEOUS-HETEROGENEOUS REACTIONS
8
Nanofluid and Micropolar Fluid Flow over a Shrinking Sheet with Heat Transfer
16
The solutions for the flow of micropolar fluid through an expanding or contracting channel with porous walls
18
BOUNDARY LAYER STAGNATION-POINT FLOW OF CASSON FLUID AND HEAT TRANSFER TOWARDS A SHRINKING/STRETCHING SHEET
9
Stagnation-point flow over a permeable stretching/shrinking sheet in a copper-water nanofluid
10
Multiple solutions of a nonlinear reactive transport model using least square pseudo-spectral collocation method
11
Coreceptor Tropism Can Be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein
10
A Dual-Mode Dual-Band Bandpass Filter Using a Single Slot Ring Resonator
8
Design and Analysis of Dual-Frequency Modified 3-Way Bagley Power Dividers
15
A search for AdS(5) X S-2 IIB supergravity solutions dual to N=2 SCFTs
23
EAI TR 10 Brochure pdf
12
Efficiency and Generalized Convex Duality for Nondifferentiable Multiobjective Programs
10
Superlinear Kirchhoff-type problems of the fractional p-Laplacian without the (AR) condition
13
Duality Theorems for Convex Semidefinite Optimization Problems with Conic Constraints
13
Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications
11